Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies William Suciangto; Haerani Rasyid; Anastasya Angelica Vicente; Winny Suciangto;

Safety and effectiveness of sucroferric oxyhydroxide in Spanish patients on dialysis: sub-analysis of the VERIFIE study María Auxiliadora Bajo; Francisco Ríos-Moreno; Maria Dolores Arenas; Ramón Jesús Devesa-Such; Maria Jose Molina-Higueras; Margarita Delgado; Pablo Molina; Nuria García-Fernández; Alejandro Martin-Malo; Roser Peiró-Jordán; Jorge Cannata-Andia; Ángel Luis Martín-De Francisco;